Mon, October 18, 2010
Sun, October 17, 2010
Fri, October 15, 2010
[ Fri, Oct 15th 2010 ]: Market Wire
AXP, DD, WMT, CHK, ECA
Thu, October 14, 2010
[ Thu, Oct 14th 2010 ]: Market Wire
JPM, BAC, PNC, C, GS
[ Thu, Oct 14th 2010 ]: Market Wire
SRE,PCG,AGL,F,HST
Wed, October 13, 2010
Tue, October 12, 2010
Mon, October 11, 2010
[ Mon, Oct 11th 2010 ]: Market Wire
JPM,BAC,THO,WFC,C
[ Mon, Oct 11th 2010 ]: Market Wire
Chesapeake Financial Shares
Fri, October 8, 2010
Thu, October 7, 2010
Wed, October 6, 2010
Tue, October 5, 2010
Mon, October 4, 2010
[ Mon, Oct 04th 2010 ]: Market Wire
00 a.m. CT

Investigation of Buyout of Capital Gold on behalf of Capital Gold Shareholders by Tripp Levy PLLC


  Copy link into your clipboard //business-finance.news-articles.net/content/201 .. apital-gold-shareholders-by-tripp-levy-pllc.html
  Print publication without navigation Published in Business and Finance on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

NEW YORK--([ BUSINESS WIRE ])--Tripp Levy PLLC, a leading national securities law firm, announces an investigation into the proposed acquisition of Capital Gold Corp. (AMEX: CDC). On October 5, 2010, it was announced that CDC entered into an agreement to be acquired by Gammon Gold, Inc. (aGammon Golda) (NYSE:[ GRS ]). Under the terms of the transaction, each common share of Capital Gold will be exchanged for 0.5209 common shares of Gammon Gold and a cash payment in the amount of $0.79 per share. The total consideration for the purchase of 100% of the fully diluted in-the-money shares of Capital Gold is approximately $288 million or $4.57 per Capital Gold share based on Gammon Golda™s closing price on September 24, 2010

The investigation concerns, among other things, whether the consideration to be paid to CDC shareholders is grossly unfair, inadequate, and substantially below the fair or inherent value of CDC. Indeed, analysts have projected that CDCa™s true inherent value is in excess of $10 per share. The investigation further concerns whether the board of directors of CDC may have breached their fiduciary duties by not acting in CDC shareholders' best interests in connection with the sale process of CDC.

If you own CDC common stock and you wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact

Tripp Levy
Tripp Levy PLLC
125 East 82nd Street
9th Floor
New York, New York
Toll Free: 877-772-3975
Email: [ contact@tripplevy.com ]

Tripp Levy PLLC is a national law firm that specializes in mergers & acquisitions, takeover litigation, shareholder rights, and corporate governance matters in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.


Publication Contributing Sources